← Back to Influence Map
Entity DossierOrganization
ASTRAZENECA PHARMACEUTICALS LP
DE · US
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$9,000,000
Connections
6
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
MMMMedicare/Medicaid
$17.3MHCRHealth Issues
$16.9MPHAPharmacy
$15.9MCPTCopyright/Patent/Trademark
$15.9MTAXTaxation/Internal Revenue Code
$15.9MTARTariff
$7.8MTRDTrade
$4.6MINSInsurance
$2.8MBUDBudget/Appropriations
$2.1MLBRLabor/Employment
$1.7MLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$15.9M
W STRATEGIES, LLC$1.1M
TODD STRATEGY GROUP$280K
PRIME POLICY GROUP$240K
Bills Referenced in Lobbying Filings
march-inPBM
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2025-1889: Global Benchmark for Efficient Drug Pricing Model | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $1,300,000 | Source |
| Lobbied on | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $700,000 | Source |
| Retained | TODD STRATEGY GROUP | Hired TODD STRATEGY GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | W STRATEGIES, LLC | Hired W STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | PRIME POLICY GROUP | Hired PRIME POLICY GROUP to lobby (4th Quarter (Oct 1 - Dec 31) 2023) | Source |